American Journal of Roentgenology · 1985 · 29 citations · 10 references
PharmacyHealth Care ManagementPharmacoeconomicsBudget Impact AnalysisHealth InsuranceVascular SurgeryDirect Medical CostsHealth Care CostsHealthcare Cost AnalysisHospital ReimbursementPeripheral Vascular Disease CareReimbursement PolicyAmbulatory Care CostsDirect Treatment CostsHospitalization CostsInpatient Prospective Payment SystemMedical Cost AnalysisPeripheral AngioplastyProcedure PricingTreatment Cost Analysis
Hospital costs and length of stay for 86 patients with peripheral vascular disease treated by bypass or percutaneous transluminal angioplasty (PTA) were assessed. The length of stay averaged 4-4.5 times longer, and the total hospital charge was 3-3.7 times greater, for bypass than for PTA. These charges are discussed in relation to current diagnosis-related groups (DRGs) and the allowed reimbursement from the Federal Prospective Payment System. In appropriately selected patients with peripheral vascular disease, PTA should be the treatment of choice from both medical and financial points of view.
10
Autogenous venous grafts ten years later.
DeWeese Ja, Rob Cg · PubMed · 1977 · 155 citations
Autologus saphenous vein femoropopliteal bypass: analysis of 298 cases.
Cutler Bs, Thompson Je, Kleinsasser Lj et al. · PubMed · 1976 · 102 citations
Comparison of conduits for leg revascularization.
R D Weisel, K.W. Johnston, RN Baird et al. · PubMed · 1981 · 76 citations